Molbio Diagnostics IPO is a mainboard IPO aggregating up to 939.85 crore rupees. The issue consists of a fresh issue of 24,80,246 shares (aggregating up to 200.15 crore rupees) and an offer for sale of 91,66,000 shares (aggregating up to 739.70 crore rupees).
The IPO opened for subscription on 10 August 2026 and closes on 12 August 2026. The basis of allotment was finalised on 13 August 2026. The shares were listed on NSE and BSE on 17 August 2026.
The price band for the IPO is set at ₹768 to ₹807 per share. The minimum amount required for a retail investor is ₹14,526 (18 shares, 1 lot). The minimum amount required for an sHNI investor is ₹2,03,364 (252 shares, 14 lots).
The final allotment price for the Molbio Diagnostics IPO was fixed at ₹807.00 per share. The shares successfully listed on the BSE at ₹980.00 per share (with a listing gain of 21.44%) and on the NSE at ₹980.00 per share (with a listing gain of 21.44%).
IIFL Capital Services Ltd, Jefferies India Pvt Ltd, Kotak Mahindra Capital Co Ltd and Motilal Oswal Investment Advisors Ltd is the lead manager and KFin Technologies is the registrar of the IPO.
Refer to Molbio Diagnostics RHP for more detailed information.
Molbio Diagnostics Share Price Analysis API (Live)
Molbio Diagnostics IPO Details Listed
IPO Issue Details
Molbio Diagnostics IPO Lot Size & Required Amount
Number of Shares Per Lot = Shares
| Application | Lot(s) | Shares | Amount |
|---|---|---|---|
Retail (Min) Minimum investment required for Retail Individual Investors (RII). | 1 | 18 | ₹14,526 |
Retail (Max) Maximum investment allowed for Retail Individual Investors (Must be under ₹2 Lakhs). | 13 | 234 | ₹1,88,838 |
S-HNI (Min) Minimum investment for Small High Net-worth Individuals (sHNI) (Must be above ₹2 Lakhs). | 14 | 252 | ₹2,03,364 |
S-HNI (Max) Maximum investment for Small High Net-worth Individuals (sHNI) (Must be up to ₹10 Lakhs). | 68 | 1224 | ₹9,87,768 |
B-HNI (Min) Minimum investment for Big High Net-worth Individuals (bHNI) (Must be above ₹10 Lakhs). | 69 | 1242 | ₹10,02,294 |
IPO Reservation
Molbio Diagnostics IPO offers total 1,16,46,246 shares (100.00%) . Out of which Not more than 50% of the offer allocated to QIB, Not less than 15% of the offer allocated to NII, Not less than 35% of the offer allocated to RII.
| Investor Category | Shares Offered |
|---|---|
|
QIB Shares Offered Qualified Institutional Buyers (e.g., mutual funds, banks). | Not more than 50% of the offer |
|
NII (HNI) Shares Offered Non-Institutional Investors, also known as High Net-worth Individuals. | Not less than 15% of the offer |
|
Retail Shares Offered Retail Individual Investors applying for up to ₹2 Lakh. | Not less than 35% of the offer |
| Total Shares Offered | 1,16,46,246 shares (100.00%) |
| 31 Mar 26 In Cr. | 31 Mar 25 In Cr. | 31 Mar 24 In Cr. | |
|---|---|---|---|
| Assets | 2,148.42 | 1,461.56 | 1,221.06 |
| Revenue | 1,455.17 | 1,027.94 | 840.66 |
| Profit After Tax | 164.14 | 138.58 | 83.54 |
| EBITDA | 328.24 | 256.64 | 185.09 |
| Net Worth | 1,144.68 | 952.95 | 807.94 |
| Total Borrowing | 412.64 | 123.16 | 174.58 |
| Reserves & Surplus | 1,148.84 | 990.84 | 845.48 |
Financial Performance Indicator (FPI)
| FPI | 31 March 2025 | 31 March 2026 |
|---|---|---|
ROE Return on Equity (ROE) is a measure of financial performance... | 16.20% | 15.59% |
ROCE Return on Capital Employed indicates how efficiently a company uses its capital. | 20.98% | 17.55% |
RoNW RoNW (Return on Net Worth) is the percentage of profit earned relative to the company's net worth and reflects overall profitability for shareholders. | 15.23% | 14.55% |
PAT Margin Profit After Tax as a percentage of revenue. Shows how much net profit is retained from every rupee of sales. | 13.48% | 11.28% |
EBITDA Margin EBITDA Margin indicates earnings before interest, tax, depreciation, and amortisation as a percentage of revenue; reflects core operating efficiency. | 24.97% | 22.56% |
Price to Book Value Compares the stock's market price to its book value per share. A higher ratio may indicate market premium. | 9.55 |
| Pre IPO | Post IPO | |
|---|---|---|
EPS Rs Earnings Per Share is a company's profit divided by outstanding shares. | 14.56 | 14.24 |
P/E (x) Price to Earnings ratio is the ratio of a stock's market price to its earnings per share. Indicates how much investors pay per rupee of earnings. | 55.43 | 56.67 |
Promoter Holding The percentage of total shares held by the company's founders or promoter group. | 46.65% | 43.01% |
Molbio Diagnostics IPO Peer Comparison
| Company Name | P/E ratio | EPS (Basic) | EPS (Diluted) | NAV (per share) | RoNW (%) | P/BV |
|---|---|---|---|---|---|---|
| Vijaya Diagnostic Centre | 81.02(Vijaya) | 16.81(Vijaya) | 16.79(Vijaya) | 93.02(Vijaya) | 18.07(Vijaya) | (Vijaya) |
| Metropolis Healthcare | 63.72(Metropolis) | 9.19(Metropolis) | 9.19(Metropolis) | 72.98(Metropolis) | 12.56(Metropolis) | (Metropolis) |
| Dr. Lal Pathlabs | 62.20(Dr.) | 30.24(Dr.) | 30.20(Dr.) | 145.00(Dr.) | 20.78(Dr.) | (Dr.) |
| Poly Medicure | 52.61(Poly) | 31.79(Poly) | 31.75(Poly) | 306.45(Poly) | 10.37(Poly) | (Poly) |
| Molbio Diagnostics | (Molbio) | 14.77(Molbio) | 14.77(Molbio) | 101.51(Molbio) | 14.55(Molbio) | (Molbio) |
IPO Subscription Status
Molbio Diagnostics IPO Frequently Asked Questions (FAQ)
Molbio Diagnostics IPO is a mainboard IPO. The company will raise upto 939.85 crore rupees for 1,16,46,246 shares. Face value is ₹1 per share, Price band is ₹768 to ₹807 per share, and cutt off price is ₹807 per share. The IPO opens on 10 August 2026 and closes on 12 August 2026. is the registrar and shares of Molbio Diagnostics IPO will be listed at NSE, BSE.
The issue size of IPO is . For fresh issue: 24,80,246 shares (aggregating up to 200.15 crore rupees) and for offer for sale: 91,66,000 shares (aggregating up to 739.70 crore rupees).
Price band for IPO is . Applying IPO application at cutt off price ₹807 per share (the upper end of price band) is considered safer than the applying IPO application at lower end of price band.
The lot size of Molbio Diagnostics IPO is of 18. Minimum order quantity for retail investor is 18 shares (1 lots) and required amount is ₹14,526. Minimum order quantity for sHNI is 252 shares (14 lots) and required amount is ₹2,03,364. Minimum order quantity for bHNI investor is 1,242 shares (69 lots) and required amount is ₹10,02,294.
The investors portion reserved for QIB is Not more than 50% of the offer, reserved for HNI is Not less than 15% of the offer and reserved for retail investors.
The IPO will be available for subscription from 10 August 2026 to 12 August 2026. IPO open date is 10 August 2026 and close date is 12 August 2026.
Allotment date for IPO is 13 August 2026. On the allotment date, After the IPO allotment status is announced, investors can check their IPO application allotment status on their respective IPO registrar.
The registrar for IPO is Kfin Technologies Ltd.
The IPO will be listed on 17 August 2026 at NSE, BSE.